DK230288A - Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling - Google Patents

Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling

Info

Publication number
DK230288A
DK230288A DK230288A DK230288A DK230288A DK 230288 A DK230288 A DK 230288A DK 230288 A DK230288 A DK 230288A DK 230288 A DK230288 A DK 230288A DK 230288 A DK230288 A DK 230288A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
pharmaceutical preparations
small pearls
pearls
Prior art date
Application number
DK230288A
Other languages
English (en)
Other versions
DK230288D0 (da
Inventor
Yatindra M Joshi
William R Bachman
Nemichand B Jain
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK230288D0 publication Critical patent/DK230288D0/da
Publication of DK230288A publication Critical patent/DK230288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK230288A 1987-04-28 1988-04-27 Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling DK230288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4358487A 1987-04-28 1987-04-28

Publications (2)

Publication Number Publication Date
DK230288D0 DK230288D0 (da) 1988-04-27
DK230288A true DK230288A (da) 1988-10-29

Family

ID=21927917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK230288A DK230288A (da) 1987-04-28 1988-04-27 Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling

Country Status (11)

Country Link
EP (1) EP0288732A3 (da)
JP (1) JPS63284123A (da)
KR (1) KR960006060B1 (da)
AU (1) AU613898B2 (da)
CA (1) CA1323833C (da)
DD (1) DD272998A5 (da)
DK (1) DK230288A (da)
HU (1) HU204694B (da)
NZ (1) NZ223713A (da)
PH (1) PH26689A (da)
ZA (1) ZA881488B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
DE4109134A1 (de) * 1991-03-20 1992-09-24 Knoll Ag Erzeugnisse, enthaltend verapamil und trandolapril
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
AU663146B2 (en) * 1991-12-30 1995-09-28 R.P. Scherer Technologies, Inc. Microcrystalline cellulose spheronization composition
GB2264639B (en) * 1992-02-20 1996-05-22 Euro Celtique Sa Modified Release Formulation
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
AU1071200A (en) * 1998-10-19 2000-05-08 Biotech Australia Pty Limited Systems for oral delivery
GB2374874A (en) * 2001-04-11 2002-10-30 Bioprogress Tech Int Inc Modified cellulose films
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
AU2003219184A1 (en) * 2002-05-09 2003-11-11 Diffucap-Chemobras Quimica E Farmaceutica, Ltda. Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
WO2005105045A1 (ja) * 2004-04-30 2005-11-10 Astellas Pharma Inc. 経口投与用時限放出型粒子状医薬組成物及び該組成物を含有する口腔内速崩壊錠

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
JPS60262919A (ja) * 1984-06-11 1985-12-26 Kawasaki Steel Corp 一方向性珪素鋼のスラブ加熱方法
JPS61125687A (ja) * 1984-11-22 1986-06-13 Hitachi Ltd パタ−ン抽出方式
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0617254B2 (ja) * 1986-05-28 1994-03-09 日産化学工業株式会社 硬化コンクリ−トの劣化防止方法

Also Published As

Publication number Publication date
JPS63284123A (ja) 1988-11-21
NZ223713A (en) 1990-06-26
PH26689A (en) 1992-09-15
CA1323833C (en) 1993-11-02
EP0288732A3 (en) 1990-11-07
DK230288D0 (da) 1988-04-27
HU204694B (en) 1992-02-28
AU613898B2 (en) 1991-08-15
DD272998A5 (de) 1989-11-01
KR880012215A (ko) 1988-11-26
ZA881488B (en) 1988-08-22
AU1283588A (en) 1988-11-03
KR960006060B1 (ko) 1996-05-08
HUT52944A (en) 1990-09-28
EP0288732A2 (en) 1988-11-02

Similar Documents

Publication Publication Date Title
DK230288A (da) Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling
NO893678D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO881344L (no) Fremgangsmaate til fremstilling av kvaternaere esteraminer og deres anvendelse.
DK396381A (da) Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling
NO900577L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO904921L (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
DK20580A (da) Kosmetiske midler og fremgangsmaade til fremstilling af deres aktive ingredienser
DK229387D0 (da) Retinoesyreestere, deres fremstilling og farmaceutiske og kosmetiske praeparater deraf
DK293888A (da) Fenolderivater og deres fremstilling og anvendelse
DK165985C (da) 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler
DK115288D0 (da) Pesticid anvendelse af 2-phenylimidazolderivater samt 2-phenyl-imidazolderivater og fremgangsmaader til deres fremstilling
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK415388A (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
DK488385A (da) N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser
NO883898D0 (no) 4-okso-3-quinolinsyrer og deres fremstilling derav.
DK289585A (da) Arylderivater af heterobicycliske forbindelser, deres farmaceutiske anvendelse og deres fremstilling
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
DK183585D0 (da) Iminothiazolidinderivater, deres fremstilling og farmaceutiske praeparater deraf
DK514989A (da) Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DK300488D0 (da) Mono- og polyhydroxyacylderivater af polyoxygenerede labdaner, deres fremstilling og anvendelse
DK261485A (da) Kosmetiske praeparater og fremgangsmaade til deres fremstilling
DK228185A (da) Nifedipinpraeparater og fremgangsmaader til deres fremstilling
NO871634D0 (no) Plantevernmidler og fremgangsmaate for deres fremstilling.
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater